PODD250117P135000
- 0.21
- 0.000.00%
Insulet Newsroom
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Express News | Insulet Shares Are Trading Higher Amid Strength in Diabetes-related Stocks Following Weight Loss Data From Novo Nordisk
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Executive VP Of Insulet Sold 26% Of Their Shares
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Redburn Atlantic Raises Price Target on Insulet to $300 From $270, Keeps Buy Rating
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Unusual Options Activity: DVN, GOOGL and Others Attract Market Bets, DVN V/OI Ratio Reaches 78.9
Another Week, Another Index Record | Lkive Stock
Weekly Buzz: Tech stocks hit high scores on ominous day
Market Mixed on Friday the 13th | Livestock
Thursday Ends in Index Declines | Wall Street Today
Insulet Is Maintained at Overweight by JP Morgan
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock